TCI Biotech introduced GLP-1 Formula™, a food-grade metabolic wellness blend designed to stimulate the body’s natural GLP-1 satiety hormone pathways through a combination of heat-killed Bifidobacterium breve, kombucha black tea ferment and Rockit apple extract. The formulation was positioned as a non-pharmacological approach to appetite regulation and post-meal metabolic support using synergistic probiotic and botanical ingredients.
Laboratory studies reported increases in GLP-1 secretion and PYY gene expression in enteroendocrine cell models, along with changes in glucose transporter activity associated with metabolic signaling. TCI also conducted a randomized crossover study in 25 adults that monitored GLP-1, glucose, insulin and appetite responses after a glucose challenge, while a larger consumer study tracked weight-management outcomes over eight weeks.
For consumers, the formula aims to support fullness and glucose control through endogenous hormonal pathways rather than pharmaceutical intervention, reflecting growing interest in food-grade metabolic health and weight-management solutions.
Food-Grade GLP-1 Stimulators
TCI Biotech Introduced Its GLP-1 Formula™
Trend Themes
-
Food-grade GLP-1 Stimulators — This trend highlights non-pharmaceutical formulations that modulate endogenous satiety hormones, enabling novel product categories that mimic drug-like metabolic effects through food ingredients.
-
Microbiome-driven Metabolic Health — Companies are leveraging heat-killed microbes and fermentation metabolites to influence enteroendocrine signaling, opening pathways for microbiome-informed metabolic interventions.
-
Botanical-probiotic Synergy — Growing evidence of complementary actions between plant extracts and probiotic-derived components is creating opportunities for multi-modal blends that target appetite and glucose regulation.
Industry Implications
-
Functional Foods & Supplements — The sector can expand into clinically positioned, food-grade products that promise hormone-mediated satiety and glycemic support without prescription drugs.
-
Clinical Nutrition & Diagnostics — Precision nutrition services and testing platforms may integrate hormone response monitoring to validate and personalize dietary interventions for metabolic outcomes.
-
Food-tech Ingredient Supply — Ingredient manufacturers could scale specialized fermented extracts and stabilized microbial preparations to meet demand for standardized, regulatory-compliant metabolic actives.